1. Home
  2. SONM vs INAB Comparison

SONM vs INAB Comparison

Compare SONM & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONM
  • INAB
  • Stock Information
  • Founded
  • SONM 1999
  • INAB 2016
  • Country
  • SONM United States
  • INAB United States
  • Employees
  • SONM N/A
  • INAB N/A
  • Industry
  • SONM Telecommunications Equipment
  • INAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • SONM Telecommunications
  • INAB Health Care
  • Exchange
  • SONM Nasdaq
  • INAB Nasdaq
  • Market Cap
  • SONM 12.1M
  • INAB 10.6M
  • IPO Year
  • SONM 2019
  • INAB 2021
  • Fundamental
  • Price
  • SONM $11.22
  • INAB $2.00
  • Analyst Decision
  • SONM
  • INAB Strong Buy
  • Analyst Count
  • SONM 0
  • INAB 2
  • Target Price
  • SONM N/A
  • INAB $108.00
  • AVG Volume (30 Days)
  • SONM 58.6K
  • INAB 66.8K
  • Earning Date
  • SONM 11-12-2025
  • INAB 11-10-2025
  • Dividend Yield
  • SONM N/A
  • INAB N/A
  • EPS Growth
  • SONM N/A
  • INAB N/A
  • EPS
  • SONM N/A
  • INAB N/A
  • Revenue
  • SONM $57,917,000.00
  • INAB N/A
  • Revenue This Year
  • SONM $127.68
  • INAB N/A
  • Revenue Next Year
  • SONM N/A
  • INAB N/A
  • P/E Ratio
  • SONM N/A
  • INAB N/A
  • Revenue Growth
  • SONM N/A
  • INAB N/A
  • 52 Week Low
  • SONM $9.38
  • INAB $1.91
  • 52 Week High
  • SONM $114.84
  • INAB $12.53
  • Technical
  • Relative Strength Index (RSI)
  • SONM 96.04
  • INAB 38.58
  • Support Level
  • SONM $0.66
  • INAB $2.04
  • Resistance Level
  • SONM $12.30
  • INAB $2.15
  • Average True Range (ATR)
  • SONM 0.31
  • INAB 0.11
  • MACD
  • SONM 1.24
  • INAB -0.02
  • Stochastic Oscillator
  • SONM 90.71
  • INAB 5.51

About SONM Sonim Technologies Inc.

Sonim Technologies Inc is a provider of ultra-rugged mobile devices, including phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The company sells mobile phones, accessories, and solutions to AT&T, T-Mobile, and Verizon in the Canada, and to Bell, Rogers, and Telus and Rogers, Telstra in Australia. The products include rugged mobile phones that can attach to both public and private wireless networks, industrial-grade accessories that meet the requirements of specific applications and software applications, and cloud-based tools that provide management and deployment services to customers. The company generates revenue from discounts, price protection, and customer incentives.

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

Share on Social Networks: